TWSTTwist Bioscience Corporation
64.57USD+6.60%Mkt Cap: 4.02B USDP/E: Last update: 2026-05-26

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food…

Indicators:|

Key Statistics

Company
Market Cap4.02B USD
Enterprise Value3.60B USD
Revenue (TTM)409.48M USD
Gross Profit191.00M USD
Net Income (TTM)-77.67M USD
Revenue/Share6.735 USD
Last Price64.57 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees979
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS90184D1000
Valuation
P/E (Trailing)
P/E (Forward)-28.70
PEG
EV/EBITDA-32.80
EV/Revenue8.80
P/S8.95
P/B8.04
EPS (TTM)-1.32
EPS (Forward)-2.05
52W Range
23.3097% of range66.06
52W High66.06 USD
52W Low23.30 USD
Profitability
Gross Margin50.72%
Oper. Margin-34.92%
EBITDA Margin-26.82%
Profit Margin-20.63%
ROE-16.42%
ROA-12.10%
Growth
Revenue Growth19.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-47.63M USD
CapEx (TTM)28.00M USD
FCF Margin-14.28%
FCF Yield-1.46%
Net Debt-60.83M USD
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.16
Current Ratio2.70
Quick Ratio2.04
Book Value/Sh7.322 USD
Cash/Share2.757 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)63.33 USD
Target Range36.00 USD75.00 USD
# Analysts9
Ownership
Shares Out.62.27M
Float55.38M
Insiders1.32%
Institutions123.97%
Short Interest
Short Ratio11.0d
Short % Float28.67%
Short % Out.22.35%
Shares Short13.91M
Short (prev mo.)14.15M
Technical
SMA 5052.69 (+22.5%)
SMA 20038.90 (+66.0%)
Beta2.23
S&P 52W Chg28.31%
Avg Vol (30d)1.52M
Avg Vol (10d)1.40M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)